NasdaqCM - Nasdaq Real Time Price USD
Rein Therapeutics Inc. (RNTX)
1.7200
+0.0900
+(5.52%)
At close: May 8 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| UNIVERSITY OF TEXAS INVESTMENT MANAGEMENT Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 17, 2024 | 1,746,550 |
| WINDSOR JAMES BRIAN Chief Executive Officer | Purchase | Dec 5, 2024 | -- |
Related Tickers
ACTU Actuate Therapeutics, Inc. Common stock
9.90
+6.45%
CUE Cue Biopharma, Inc.
0.7680
-0.05%
RNXT RenovoRx, Inc.
1.0400
-0.95%
INAB IN8bio, Inc.
0.1679
+2.07%
COYA Coya Therapeutics, Inc.
6.21
+4.02%
DNTH Dianthus Therapeutics, Inc.
20.62
+3.25%
4587.T PeptiDream Inc.
1,916.50
+1.16%
NMTRQ 9 Meters Biopharma, Inc.
0.0001
0.00%
4565.T Nxera Pharma Co., Ltd.
876.00
-0.23%
CGTX Cognition Therapeutics, Inc.
0.3300
-6.96%